Bayer and UK biotech Bicycle Therapeutics have agreed to collaborate to develop and commercialize the latter’s radioconjugates for multiple oncology targets.
01.06.2017
- UK biotech Bicycle Therapeutics has raised £40 million from a Series B financing round to advance the development of multiple candidate drugs to treat cancers with a high unmet...
